IMMPF
Price:
$0.085
Market Cap:
$29.46M
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The compan...[Read more]
Industry
Biotechnology
IPO Date
2017-02-08
Stock Exchange
OTC
Ticker
IMMPF
According to ImmuPharma plc’s latest financial reports and current stock price. The company's current ROE is 3.82%. This represents a change of -9640.61% compared to the average of -40.01% of the last 4 quarters.
The mean historical ROE of ImmuPharma plc over the last ten years is -93.78%. The current 3.82% ROE has changed -4170.69% with respect to the historical average. Over the past ten years (40 quarters), IMMPF's ROE was at its highest in in the September 2024 quarter at 193.05%. The ROE was at its lowest in in the March 2025 quarter at -273.07%.
Average
-93.78%
Median
-133.55%
Minimum
-276.63%
Maximum
457.39%
Discovering the peaks and valleys of ImmuPharma plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 358.13%
Maximum Annual ROE = 457.39%
Minimum Annual Increase = -265.35%
Minimum Annual ROE = -276.63%
| Year | ROE | Change |
|---|---|---|
| 2024 | 457.39% | -265.35% |
| 2023 | -276.63% | 83.36% |
| 2022 | -150.87% | -18.54% |
| 2021 | -185.20% | 160.66% |
| 2020 | -71.05% | -38.86% |
| 2019 | -116.22% | 22.93% |
| 2018 | -94.54% | -45.69% |
| 2017 | -174.09% | 81.36% |
| 2016 | -96.00% | -58.36% |
| 2015 | -230.54% | 358.13% |
The current ROE of ImmuPharma plc (IMMPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
9.97%
5-year avg
-45.27%
10-year avg
-93.78%
ImmuPharma plc’s ROE is less than IntelGenx Technologies Corp. (126.70%), greater than LakeShore Biopharma Co., Ltd (-18.43%), greater than IBEX Technologies Inc. (33.34%), less than OKYO Pharma Limited (73.68%), greater than Kadimastem Ltd (0.16%), less than Alpha Cognition Inc. (184.34%), greater than Small Pharma Inc. (-78.43%), less than Organicell Regenerative Medicine, Inc. (219.09%), less than Generation Hemp, Inc. (7.87%), less than Chill Brands Group PLC (897.79%),
| Company | ROE | Market cap |
|---|---|---|
| 126.70% | $29.69M | |
| -18.43% | $34.62M | |
| 33.34% | $25.27M | |
| 73.68% | $22.73M | |
| 0.16% | $9.50M | |
| 184.34% | $35.66M | |
| -78.43% | $37.51M | |
| 219.09% | $19.97M | |
| 7.87% | $25.34M | |
| 897.79% | $24.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuPharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ImmuPharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ImmuPharma plc's ROE?
How is the ROE calculated for ImmuPharma plc (IMMPF)?
What is the highest ROE for ImmuPharma plc (IMMPF)?
What is the 3-year average ROE for ImmuPharma plc (IMMPF)?
What is the 5-year average ROE for ImmuPharma plc (IMMPF)?
How does the current ROE for ImmuPharma plc (IMMPF) compare to its historical average?